Atlantic Chapter

Explore, enjoy, and protect the planet.

Endocrine-Disrupting Chemicals Exposure Elimination Act ( 2011- S. 1361, HR. 2521)

The following is from an endorsement letter by the American Academy of Pediatrics

This legislation would establish a panel of experts through the National Toxicology Program’s Board of Scientific Counselors to evaluate existing research and identify future research of endocrine disrupting chemicals. The panel would develop and update an annual list of chemicals of concern, advise the Environmental Protection Agency (EPA) and the Food and Drug Administration (FDA), and provide information to Congress regarding the human health impacts of endocrine disruptors. For any chemical determined to be an actual or potential endocrine disruptor, H.R. 2521 requires that the level of evidence, the level of concern, and the pathways of exposure of those chemicals be determined. In addition, when a chemical reaches the minimum level of concern, the FDA and EPA must develop a strategy to reduce exposure and work with industry to implement measures to reduce human exposure. Further, if there is a high level of concern for a specific chemical, the chemical would be banned unless the pathways to human exposure are mitigated.



Wednesday, September 12, 2012
Website Section: